High-alert and look-alike/sound-alike medications

High-Alert and Look-Alike/Sound-Alike Medications

Some medication errors cause little harm. Others kill. Understanding which drugs carry the greatest risk—and knowing proven strategies to prevent mix-ups—is one of the most important safety skills a pharmacy technician can develop.

What Are High-Alert Medications?

High-alert medications are drugs that carry a heightened risk of causing significant patient harm when used in error. The error itself may not be more common than with other drugs, but the consequences are far more severe. The Institute for Safe Medication Practices (ISMP) publishes and regularly updates lists of high-alert medications for community, acute care, and long-term care settings.

Common categories on ISMP high-alert lists include:

• Anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants) — narrow margin between therapeutic and dangerous blood levels
• Insulin — wrong concentration, type, or dose can cause life-threatening hypoglycemia
• Opioids — respiratory depression risk; multiple concentrations and formulations exist
• Concentrated electrolytes (e.g., concentrated potassium chloride for injection) — potentially fatal if administered undiluted
• Chemotherapy agents — narrow therapeutic index and serious toxicity
• Neuromuscular blocking agents — can cause respiratory arrest if confused with other injectables

Pharmacy technicians must recognize these categories and apply extra verification steps whenever they are involved in processing, filling, or stocking these medications.

What Are Look-Alike/Sound-Alike (LASA) Medications?

Look-alike/sound-alike (LASA) medications are pairs or groups of drugs whose names, packaging, or physical appearance are similar enough to be confused with one another. ISMP maintains a widely used LASA list. The FDA also tracks names that cause confusion and has authority to require name changes.

Examples of well-known LASA pairs include:

• HydrALAZINE / HydrOXYzine — one treats hypertension; the other is an antihistamine/anxiolytic
• predniSONE / prednisoLONE — both corticosteroids but not interchangeable in all situations
• vinBLAStine / vinCRIStine — both chemotherapy agents; mix-ups have caused deaths
• glipiZIDE / glyBURIDE — both oral antidiabetics but different potency profiles
• metFORMIN / metroNIDAZOLE — one for diabetes, one an antibiotic

LASA errors occur at every step: prescribing, transcribing, dispensing, and administration. Technicians can interrupt the error chain at the dispensing step.

Tall-Man Lettering

Tall-man lettering (also called mixed-case lettering) is a risk-reduction strategy endorsed by ISMP and adopted by the FDA and many health systems. It uses uppercase letters to highlight the part of a drug name that differs between look-alike pairs, drawing the eye to the distinguishing syllables.

Examples:

• hydrALAZINE vs. hydrOXYzine
• vinBLAStine vs. vinCRIStine
• predniSONE vs. prednisoLONE

When redesigning or reviewing labels, technicians should apply tall-man lettering consistently, following the ISMP or FDA recommended style for that specific drug name. Do not create your own capitalization patterns for established pairs—use the published standard.

Physical Separation of LASA Products

Storing LASA medications next to each other on a shelf dramatically increases the chance of a grab error. Best practices include:

• Physically separate LASA pairs in storage—do not shelve them adjacent to each other
• Use auxiliary warning labels on bins and shelves (e.g., "WARNING: LASA Drug — Verify Before Dispensing")
• Apply color-coded shelf stickers or shelf talkers to flag high-alert or LASA products
• Maintain separate bins for different concentrations of the same drug (e.g., different insulin products)

During a shelf audit, technicians systematically walk through storage areas to identify LASA pairs stored too close together, missing warning labels, or products that need tall-man lettering on bin labels.

Barcode Verification

Barcode medication administration (BCMA) and barcode scanning at the point of dispensing are powerful checks against LASA and high-alert errors. Scanning the barcode on the manufacturer's product confirms the correct drug, strength, and dosage form before a product is placed in a patient's medication drawer or a prescription bag.

Technicians should:

• Always scan the barcode rather than relying on visual inspection alone when technology is available
• Report any barcode that does not scan or triggers an override alert — never silence an alert without investigation
• Be aware that barcode systems are not foolproof: labels can be damaged, or a wrong product may have been placed in the correct bin — visual verification still matters

Your Role and Scope

Pharmacy technicians do not independently make clinical decisions about therapy, but they are a critical safety layer. When you identify a potential LASA or high-alert concern during dispensing, stop and verify with the pharmacist before proceeding. Document near-misses using your pharmacy's error-reporting system. Reporting near-misses helps identify system weaknesses before a patient is harmed.

Patient safety is not one person's responsibility — it is built into every step of the dispensing process, and your attention at each step saves lives.